The Bowdoin Group Completes Commercial Expansion for ARAID Pharmaceuticals
Placements | Press Releases
Posted by Bowdoin on March 5, 2025
WALTHAM, Mass., July 21, 2016 – The Bowdoin Group announced today they have completed a large-scale national commercial and medical affairs expansion on behalf of their client, ARIAD Pharmaceuticals, a leading orphan oncology company focused on transforming the lives of cancer patients with breakthrough medicines. Through extensive oncology industry experience and operational efficiency coordinating national panel interviews across the United States, Bowdoin hired over thirty exceptional people as Account Managers, Regional Directors, and Medical Science Liaisons for the Cambridge-based biotechnology firm, all within six weeks.
“We were tasked with doubling the current US Field Regional Account Manager team as well as adding leadership positions, [all of which was] to occur between the March and June time frame,” said David Crist, National Sales Director at ARIAD, “Bowdoin joined the existing ARIAD leadership team in development of the objectives, goals, and timelines as if it were their own. This expansion could not have been possible without Bowdoin’s team and the expert attention to detail.”
Of this recent success, The Bowdoin Group Founder and CEO David Melville said, “We are thrilled to have delivered excellence once again, and to have done so for a client of such caliber as ARIAD. With a dedicated team of six Bowdoin sales and operations members, we were able to tailor a specific hiring strategy unique to our client, and the work paid off with excellent results.”
“Bowdoin not only said this was possible, they showed us how,” said Tiffany Patrick, Senior Director, U.S. Medical Affairs at ARIAD, “Their approach to partnership, communication, and their attention to detail was the key. As soon as we brought The Bowdoin Group in, it felt like I had a large recruiting team on my side. We hired top talent. We were able to be competitive in a competitive space as a small company… weeks ahead of schedule.”
About ARIAD Pharmaceuticals
AARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
About The Bowdoin Group
Founded in 1994, The Bowdoin Group is an award-winning healthcare and life sciences executive search and strategic talent partner helping high-growth companies build the leadership and teams they need to scale. With deep sector expertise and a business–led talent approach, Bowdoin partners with executive teams, boards, and investors to deliver executive search, strategic search, and team build solutions across every stage of company growth.
Visit us at https://www.bowdoingroup.com and connect with us on LinkedIn.
Contact
Marle Van Siclen
Head of Marketing
mvansiclen@bowdoingroup.com